Matthew Harris

532 total citations
17 papers, 319 citations indexed

About

Matthew Harris is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Matthew Harris has authored 17 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 2 papers in Oncology. Recurrent topics in Matthew Harris's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (6 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Matthew Harris is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (6 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Matthew Harris collaborates with scholars based in United Kingdom, United States and Indonesia. Matthew Harris's co-authors include Graham Ladds, David R. Poyner, Ian J. Winfield, Christopher A. Reynolds, Junmin Peng, Maria Martí-Solano, Graeme Milligan, Andrew B. Tobin, Simon J. Dowell and Amanda E. Mackenzie and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Matthew Harris

15 papers receiving 317 citations

Peers

Matthew Harris

CMN

ONCOL

EDM

PMH

Élodie Archer-Lahlou Canada

Wen-Ji Chen United States

Catherine Lavoie Canada

Nicola Robas United Kingdom

Florence Gross Canada

Alison J. McLean United Kingdom

Thomas R. McMinn United States

Wayne Stallaert United States

Khaled Alganem United States

Tatsuo Sugawara Germany

Élodie Archer-Lahlou Canada

Matthew Harris

304 ×1.2

240 ×1.4

CMN

79 ×1.9

ONCOL

21 ×0.5

EDM

14 ×0.4

PMH

Citations per year, relative to Matthew Harris Matthew Harris (= 1×) peers Élodie Archer-Lahlou

Countries citing papers authored by Matthew Harris

Since Specialization

Citations

This map shows the geographic impact of Matthew Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Harris more than expected).

Fields of papers citing papers by Matthew Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Harris. The network helps show where Matthew Harris may publish in the future.

Co-authorship network of co-authors of Matthew Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Harris. A scholar is included among the top collaborators of Matthew Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Harris. Matthew Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Harris, Matthew, et al.. (2025). Receptor activity–modifying protein 3 enhances GLP-1-mediated insulin secretion. Journal of Biological Chemistry. 301(10). 110604–110604.

Jones, Andrew J. Y., et al.. (2024). Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor. Nature Communications. 15(1). 1334–1334. 10 indexed citations

Davies, Amy, Matthew Harris, George Lambrinidis, et al.. (2024). Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. Journal of Medicinal Chemistry. 67(15). 13117–13146.

Winfield, Ian J., Sarah J Routledge, N.J. Robertson, et al.. (2022). The Role of ICL1 and H8 in Class B1 GPCRs; Implications for Receptor Activation. Frontiers in Endocrinology. 12. 792912–792912. 5 indexed citations

Harris, Matthew, et al.. (2022). Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias. Frontiers in Physiology. 13. 840763–840763. 9 indexed citations

Mullooly, N, Matthew Harris, Tessa de Vries, et al.. (2021). CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells. Communications Biology. 4(1). 776–776. 25 indexed citations

Harris, Matthew, et al.. (2021). Measuring the rapid kinetics of receptor-ligand interactions in live cells using NanoBRET. Methods in cell biology. 166. 1–14. 2 indexed citations

Ahmed, Samrein B. M., et al.. (2021). A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases. Biochemistry. 60(19). 1533–1551. 17 indexed citations

Wang, Haonan, et al.. (2020). Hippocampal T2 signal loss and decreased radial arm maze performance in transgenic murine model for AD. 5(1). 2 indexed citations

10.

Martí-Solano, Maria, Duccio Malinverni, Christian Munk, et al.. (2020). Combinatorial expression of GPCR isoforms affects signalling and drug responses. Nature. 587(7835). 650–656. 90 indexed citations

11.

Harris, Matthew, Ian J. Winfield, Fredrik Svensson, et al.. (2020). Elevated intracellular cAMP concentration mediates growth suppression in glioma cells. Biochemical Pharmacology. 174. 113823–113823. 18 indexed citations

12.

Harris, Matthew, Scott M. Ebert, Jason M. Dierdorff, et al.. (2020). Skeletal Muscle ULK1 and ULK2 Jointly Couple Muscle Mass with Force and Are Required for Survival Under Low Nutrient Availability. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

13.

Harris, Matthew, et al.. (2020). Embryonic versus adult cardiomyocyte loss of ULK1 and ULK2 uncover temporally distinct effects on autophagy and cardiac function. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

14.

Harris, Matthew, Ian J. Winfield, Matthew T. Harper, et al.. (2019). Interactions between RAMP2 and CRF receptors: The effect of receptor subtypes, splice variants and cell context. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1861(5). 997–1003. 14 indexed citations

15.

Harris, Matthew, et al.. (2019). RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis. Proceedings of the National Academy of Sciences. 116(48). 24093–24099. 39 indexed citations

16.

Harris, Matthew, et al.. (2018). Emerging patents in the therapeutic areas of glioma and glioblastoma. Expert Opinion on Therapeutic Patents. 28(7). 573–590. 10 indexed citations

17.

Weston, Cathryn, Ian J. Winfield, Matthew Harris, et al.. (2016). Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors. Journal of Biological Chemistry. 291(42). 21925–21944. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact